Sun Pharma launches CEQUA for treatment of dry eye disease in US
Sun Pharma introduces CEQUA SUPPORTTM Specialty Pharmacy programme to enable easy access for patients to obtain treatment
Sun…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sun Pharmaceutical Industries
Sun Pharma presents follow-up data from ILUMYA Phase 3 reSURFACE 1 and 2 trials
Additional data show people with and without metabolic syndrome respond similarly to ILUMYA treatment with comparable, positive…
Sun Pharma arm acquires remaining 3.04 per cent stake in PJSC Biosintez
The company's subsidiary - Sun Pharma (Netherlands) BV - already had 96.96 per cent stake in pharma firm PJSC Biosintez prior to…
Sebi orders forensic audit of Sun Pharma financial statements from FY16-18
Sun Pharma, however, did not provide any specific details on the reasons for the Securities and Exchange Board of India to order…
Sun Pharma gives commercialisation license to CMS for seven products
The collaboration with China Medical System Holdings now covers eight generic products including the seven products referred above
Pharma packaging: An evolving sphere
Pharma companies looking at newer methods and approaches to minimise packaging costs and yet meet important goals such as…
Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in US
The drug has some presence of 'unknown impurity', which was manufactured at the company's Halol facility in Gujarat
Around 3.8…
Sun completes sale of two Ranbaxy divisions to Strides Shasun
The agreement involved transfer of these two marketing divisions, along with employees to Strides, for Rs 165 crore
Sun…
Sun Pharma raises Rs 1,000 crore via NCDs
NCDs will be listed on BSE under two series
Sun Pharmaceutical Industries has raised Rs 1,000 crore through issuance of…
Sun Pharma receives warning letter for Halol facility
The company expects a re-inspection by US FDA
Sun Pharmaceutical Industries has received a warning letter from the US FDA as a…